Troglitazone acutely inhibits protein synthesis in endothelial cells via a novel mechanism involving protein phosphatase 2A-dependent p70 S6 kinase inhibition.

MLA

Cho, Du-Hyong, et al. “Troglitazone Acutely Inhibits Protein Synthesis in Endothelial Cells via a Novel Mechanism Involving Protein Phosphatase 2A-Dependent P70 S6 Kinase Inhibition.” American Journal of Physiology. Cell Physiology, vol. 291, no. 2, Aug. 2006, pp. C317–26. EBSCOhost, https://doi.org/10.1152/ajpcell.00491.2005.

APA

Cho, D.-H., Choi, Y. J., Jo, S. A., Ryou, J., Kim, J. Y., Chung, J., & Jo, I. (2006). Troglitazone acutely inhibits protein synthesis in endothelial cells via a novel mechanism involving protein phosphatase 2A-dependent p70 S6 kinase inhibition. American Journal of Physiology. Cell Physiology, 291(2), C317–C326. https://doi.org/10.1152/ajpcell.00491.2005

Chicago

Cho, Du-Hyong, Yoon Jung Choi, Sangmee Ahn Jo, Jungsang Ryou, Jin Yi Kim, Jongkyeong Chung, and Inho Jo. 2006. “Troglitazone Acutely Inhibits Protein Synthesis in Endothelial Cells via a Novel Mechanism Involving Protein Phosphatase 2A-Dependent P70 S6 Kinase Inhibition.” American Journal of Physiology. Cell Physiology 291 (2): C317–26. doi:10.1152/ajpcell.00491.2005.